Table 1.
|
All stroke patients |
Cardioembolic stroke group |
Atherosclerotic stroke group |
P value |
---|---|---|---|---|
N 633 | N 256 (40) | N 377 (59.9) | ||
Gender men/women |
406 (64) |
163 (40) |
243 (59.9) |
0.45 |
BMI obese
*
|
356 (56.2) |
142 (40) |
214 (60) |
0.76 |
Ischemic heart disease |
142 (22.4) |
77 (54.2) |
65 (45.8) |
0.00 |
Previous MI |
47 (7.4) |
25 (53.2) |
22 (46.8) |
0.04 |
Acute MI |
18 (2.8) |
13 (72.2) |
5 (27.8) |
< .00 |
Type II DM |
325 (51.3) |
132 (40.6) |
193 (59.4) |
0.49 |
Hypertension |
500 (79) |
201 (40.2) |
299 (59.8) |
0.44 |
Cardiac valve prosthetic |
9 (1.4) |
7 (77.8) |
2 (22.2) |
0.02 |
Atrial fibrillation |
51 (8.1) |
40 (78.4) |
11 (21.6) |
0.00 |
Valvular heart disease |
5 (0.8) |
4 (80) |
1 (20) |
0.09 |
Dyslipidemia |
336 (53) |
128 (38) |
208 (61.9) |
0.11 |
Tobacco use |
109 (16.9) |
45 (42) |
62 (57.9) |
0.39 |
Prior stroke |
145 (22.9) |
57 (39.3) |
88 (60.7) |
0.41 |
Heart failure | 57 (1.1) | 5 (71.4) | 2 (28.6) | 0.09 |
*Asia Pacific Criteria for obesity as applicable to South Asians is used to define this population.
Legend: Patients with cardioembolism have more ischemic heart disease, heart failure, valvular heart disease and replacements, atrial fibrillation as compared to patients with atherosclerotic stroke.